373-22-8

Usage

Uses

Used in Solvent Applications:
2-(2-fluoroethoxy)ethanol is used as a solvent in various industrial processes due to its ability to dissolve a wide range of substances, making it a versatile component in the production of different products.
Used in Pesticide Production:
In the agricultural industry, 2-(2-fluoroethoxy)ethanol is used as a key component in the manufacturing of pesticides. Its solvent properties facilitate the effective delivery of active ingredients, enhancing the performance and efficiency of these products.
Used in Dye Manufacturing:
2-(2-fluoroethoxy)ethanol is utilized in the dye industry as a solvent for dyestuffs, contributing to the production of vibrant and long-lasting colors in textiles and other materials.
Used in Pharmaceutical Development:
Within the pharmaceutical sector, 2-(2-fluoroethoxy)ethanol serves as a solvent in the synthesis of various drugs, aiding in the development of new medications and improving the manufacturing process.

InChI:InChI=1/C4H9FO2/c5-1-3-7-4-2-6/h6H,1-4H2

Upstream product

• 75-21-8 oxirane 
• 371-62-0 2-fluoroethanol 
• 96-49-1 [1,3]-dioxolan-2-one 
• 1262964-31-7 ((2-(2-fluoroethoxy)ethoxy)methyl)benzene 

Downstream Products

• 1118567-11-5 2-(2-fluoroethoxy)ethyl 4-methylbenzenesulfonate 
• 463-39-8 1,13-difluoro-3,6,8,11-tetraoxa-tridecane 

Relevant academic research and scientific papers

GRANZYME B DIRECTED IMAGING AND THERAPY

Provided herein are compounds of Formula (I) below that are useful for imaging Granzyme B. Methods of imaging Granzyme B and treating an immunoregulatory abnormality, pharmaceutical compositions, and kits comprising the Granzyme B imaging agents are also provided.

Towards the development of new subtype-specific muscarinic receptor radiopharmaceuticals - Radiosynthesis and ex vivo biodistribution of [ 18F]3-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethylthio)-1,2, 5-thiadiazol-3-yl)-1-methyl-1,2,5,6-tetrahydropyrid

Muscarinic receptors have been implicated in neurological disorders including Alzheimer's disease, Parkinson's disease, and schizophrenia. Nineteen derivatives of thiadiazolyltetrahydropyridine (TZTP), a core that has previously shown high affinities towa

BENZYLBENZENE DERIVATIVES AND METHODS OF USE

Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.